Literature DB >> 8443598

Modulation of antibody affinity by a non-contact residue.

J F Schillbach1, R I Near, R E Bruccoleri, E Haber, P D Jeffrey, J Novotny, S Sheriff, M N Margolies.   

Abstract

Antibody LB4, produced by a spontaneous variant of the murine anti-digoxin monoclonal antibody 26-10, has an affinity for digoxin two orders of magnitude lower than that of the parent antibody due to replacement of serine with phenylalanine at position 52 of the heavy chain variable region (Schildbach, J.F., Panka, D.J., Parks, D.R., et al., 1991, J. Biol. Chem. 266, 4640-4647). To examine the basis for the decreased affinity, a panel of engineered antibodies with substitutions at position 52 was created, and their affinities for digoxin were measured. The antibody affinities decreased concomitantly with increasing size of the substituted side chains, although the shape of the side chains also influenced affinity. The crystal structure of the 26-10 Fab complexed with digoxin (P.D.J., R.K. Strong, L.C. Sieker, C. Chang, R.L. Campbell, G.A. Petsko, E.H., M.N.M., & S.S., submitted for publication) shows that the serine at heavy chain position 52 is not in contact with hapten, but is adjacent to a tyrosine at heavy chain position 33 that is a contact residue. The mutant antibodies were modeled by applying a conformational search procedure to position side chains, using the 26-10 Fab crystal structure as a starting point. The results suggest that each of the substituted side chains may be accommodated within the antibody without substantial structural rearrangement, and that none of these substituted side chains are able to contact hapten. These modeling results are consistent with the substituents at position 52 having only an indirect influence upon antibody affinity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443598      PMCID: PMC2142342          DOI: 10.1002/pro.5560020209

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

Review 1.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

2.  On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.

Authors:  E A Padlan
Journal:  Proteins       Date:  1990

3.  On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5.

Authors:  J Novotny; R E Bruccoleri; F A Saul
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

4.  Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex.

Authors:  E A Padlan; E W Silverton; S Sheriff; G H Cohen; S J Smith-Gill; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution.

Authors:  S Sheriff; W A Hendrickson; J L Smith
Journal:  J Mol Biol       Date:  1987-09-20       Impact factor: 5.469

6.  Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies.

Authors:  D J Panka; M Mudgett-Hunter; D R Parks; L L Peterson; L A Herzenberg; E Haber; M N Margolies
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

7.  Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol.

Authors:  J N Herron; X M He; M L Mason; E W Voss; A B Edmundson
Journal:  Proteins       Date:  1989

8.  Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes.

Authors:  R I Near; S C Ng; M Mudgett-Hunter; N W Hudson; M N Margolies; J G Seidman; E Haber; M A Jacobson
Journal:  Mol Immunol       Date:  1990-09       Impact factor: 4.407

9.  Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.

Authors:  N C Chien; V A Roberts; A M Giusti; M D Scharff; E D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Reshaping human antibodies for therapy.

Authors:  L Riechmann; M Clark; H Waldmann; G Winter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

View more
  7 in total

1.  Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.

Authors:  J F Schildbach; S Y Shaw; R E Bruccoleri; E Haber; L A Herzenberg; G C Jager; P D Jeffrey; D J Panka; D R Parks; R I Near
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

2.  26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.

Authors:  P D Jeffrey; R K Strong; L C Sieker; C Y Chang; R L Campbell; G A Petsko; E Haber; M N Margolies; S Sheriff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

3.  Closely related antibody receptors exploit fundamentally different strategies for steroid recognition.

Authors:  Petra Verdino; Caroline Aldag; Donald Hilvert; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

4.  Basic research in HIV vaccinology is hampered by reductionist thinking.

Authors:  Marc H V Van Regenmortel
Journal:  Front Immunol       Date:  2012-07-09       Impact factor: 7.561

Review 5.  An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine.

Authors:  Marc H V Van Regenmortel
Journal:  Front Immunol       Date:  2014-11-18       Impact factor: 7.561

6.  The structural repertoire of the human V kappa domain.

Authors:  I M Tomlinson; J P Cox; E Gherardi; A M Lesk; C Chothia
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

7.  An efficient visualization tool for the analysis of protein mutation matrices.

Authors:  Maria Pamela C David; Carlo M Lapid; Vincent Ricardo M Daria
Journal:  BMC Bioinformatics       Date:  2008-04-28       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.